➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
McKesson
Merck
Baxter
Dow

Last Updated: January 25, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Voclosporin

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Voclosporin?

Voclosporin is an investigational drug.

There have been 17 clinical trials for Voclosporin. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2011.

The most common disease conditions in clinical trials are Nephritis, Lupus Nephritis, and Keratoconjunctivitis Sicca. The leading clinical trial sponsors are Aurinia Pharmaceuticals Inc., Lux Biosciences, Inc., and Leiden University Medical Center.

Recent Clinical Trials for Voclosporin
TitleSponsorPhase
Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant RecipientsAurinia Pharmaceuticals Inc.Phase 2
Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant RecipientsLeiden University Medical CenterPhase 2
Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye SyndromeAurinia Pharmaceuticals Inc.Phase 2/Phase 3

See all Voclosporin clinical trials

Clinical Trial Summary for Voclosporin

Top disease conditions for Voclosporin
Top clinical trial sponsors for Voclosporin

See all Voclosporin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
McKesson
Merck
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.